Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,814.85
+22.15 (1.24%)
At close: Jun 23, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 344.41 billion as of June 23, 2026. Its market cap has increased by 37.44% in one year.
Market Cap
344.41B
Enterprise Value
358.41B
Revenue
92.04B
Ranking
n/a
PE Ratio
37.26
Stock Price
1,814.85
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 344.41B, an increase of 34.04%. That is a compound annual growth rate of 16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 344.41B | 33.14% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |